ArticleFrontiers in medicine2026
Risk factors and prediction model for chronic bacterial infection in stable bronchiectasis in Shanghai, China.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic bacterial infection (CBI) represents a key feature in patients with bronchiectasis. Therefore, it is of great clinical significance to develop an effective nomogram model for predicting the risk of CBI in stable bronchiectasis, which guides individualized clinical treatment strategies. Methods: The study enrolled patients in stable bronchiectasis in Shanghai between January 2020 and December 2024. They were categorized into two groups of CBI and without CBI. We used Univariate logistic analysis, LASSO regression and Multivariate logistic analysis to identify predictors associated with CBI. Based on the screened-out risk factors, a nomogram was constructed to predict the risk of CBI in adults with stable bronchiectasis. We used receiver operating characteristic, the area under the curve (AUC) and calibration curve to determine the predictive accuracy and discriminability of nomogram. The decision curve analysis (DCA) was employed to further confirm the clinical effectiveness of nomogram. Results: Multivariate logistic analysis revealed the risk factors of CBI included history of smoking, number of lobes affected ≥3, number of exacerbation in the prior year ≥3, history of hemoptysis in the prior year, CRP, CD3 Conclusion: The nomogram model demonstrated satisfactory discrimination and calibration accuracy, enabling screen patients with stable bronchiectasis at high risk of CBI and facilitating individualized clinical decisions in future clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.